Warfarin-induced Eosinophilia in a Child with urkitt Lymphoma: A Case Report
| Author | Kourosh Goudarzipour | en |
| Author | Farid Ghazizadeh | en |
| Author | Hesameddin Hoseini Tavassol | en |
| Author | Behdad Behnam | en |
| Issued Date | 2015-07-31 | en |
| Abstract | An important complication of chemotherapy is thromboembolic events that can occur during treatment course. In this way, Warfarin can be used as an efficient prophylactic agent to prevent these complications. Although bleeding is a common adverse effect of Warfarin, eosinophilia is a rare side effect of this drug. We have reported a 5-year-old boy with Burkitt lymphoma who underwent chemotherapy. In the course of chemotherapy, because of thrombosis of the left jugular vein, we initiated Warfarin as a prophylactic drug for TEE secondary to chemotherapy. Following Warfarin initiation, eosinophilia appeared and subsequent to cessation of drug, eosinophilia disappeared. | en |
| DOI | https://doi.org/10.22037/ijpr.2015.1680 | en |
| Keyword | Warfarin | en |
| Keyword | Eosinophilia | en |
| Keyword | Anticoagulant therapy | en |
| Keyword | Burkitt lymphoma | en |
| Keyword | Pediatrics | en |
| Publisher | Brieflands | en |
| Title | Warfarin-induced Eosinophilia in a Child with urkitt Lymphoma: A Case Report | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-14-887.pdf
- Size:
- 491.44 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF